Beranda › Kanker Paru Non-Sel Kecil › Texas › League City
Uji klinis Kanker Paru Non-Sel Kecil di League City, TX
15 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar League City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Menerima pesertaFase 3
- University Of Texas Medical Branch At Galveston, Galveston · 23 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
- Texas Oncology - Gulf Coast, Webster · 3 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Kelsey-Seybold Clinic - Bay Area Campus Building A, Webster · 3 mi jauhnya
- Kelsey-Seybold Clinic - Bay Area Campus Building B, Webster · 3 mi jauhnya
- Kelsey-Seybold Clinic - Bay Area Campus Building C, Webster · 3 mi jauhnya
- dan 1 lainnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Texas Oncology-Gulf Coast, Webster · 3 mi jauhnya
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Menerima pesertaFase 1
- Research Site, Galveston · 23 mi jauhnya
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- University of Texas Medical Branch, Galveston · 23 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Menerima pesertaFase 3
- Local Institution - 0692, Galveston · 23 mi jauhnya
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Menerima pesertaFase 3
- Clinical Study Site, Webster · 3 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- USO - Texas Oncology, Webster · 3 mi jauhnya
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Webster · 3 mi jauhnya
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Tranquil Clinical Research, Webster · 3 mi jauhnya
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- MD Anderson League City, League City
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Menerima peserta
- University of Texas Medical Branch at Galveston, Galveston · 23 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di League City
- Kanker Payudara12 studi
- Kanker Metastatik7 studi
- Kolitis Ulseratif6 studi
- Kanker Paru6 studi
- Kanker Kolorektal6 studi
- Kanker (semua jenis)5 studi
- Kanker Ovarium5 studi
- Stroke5 studi
- Kanker Kandung Kemih4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
- Kanker Prostat4 studi
- Kondisi Pasca-COVID (Long COVID)3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.